0HRS.L

CVS Health Corporation [0HRS.L] Stock Forecast

Q: What is CVS Health Corporation stock symbol ?

CVS Health Corporation is a US stock, located in Woonsocket of Ri and trading under the symbol 0HRS.L

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

0HRS.L Stock Summary

Earnings have grown 10.99% per last year.

Earnings are expected to fall -100% next year

Top 10 Correlated ETFs

0HRS.L

Top 10 Correlated Stocks

0HRS.L

In the News

0HRS.L Financial details

Company Rating

Strong Buy

Market Cap

86.55B

Income

8.34B

Revenue

358.27B

Book val./share

59.36

Cash/share

8.96

Dividend

1.82

Dividend %

2.26%

Employees

219K

Optionable

Shortable

Yes

Earnings

01 May 2024

P/E

12.08

Forward P/E

PEG

1.24

P/S

0.3

P/B

1.4

P/C

7.7

P/FCF

9.16

Quick Ratio

0.57

Current Ratio

0.86

Debt / Equity

0.81

LT Debt / Equity

0.75

EPS (TTM)

6.49

EPS next Y

EPS next Q

EPS this Y

97.26%

EPS next Y

EPS next 5Y

EPS last 5Y

4.94%

Revenue last 5Y

6.91%

Revenue Q/Q

4.51%

EPS Q/Q

-9.66%

SMA20

-9.09%

SMA50

-5.41%

SMA100

1.45%

Inst Own

Inst Trans

ROA

ROE

12%

ROC

0.08%

Gross Margin

15%

Oper. Margin

Profit Margin

Payout

36%

Shs Outstand

Shs Float

Target Price

52W Range

64.39-83.165

52W High

-16.92%

52W Low

+7.75%

RSI

Rel Volume

0.34

Avg Volume

34.8K

Volume

11.96K

Perf Week

-2.78%

Perf Month

-7.21%

Perf Quarter

0.47%

Perf Half Y

-4.71%

Beta

0.511

Volatility

0.52%, 3.65%

Prev Close

0.64%

Price

68.96

Change

-0.27%

0HRS.L Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-12-31

Metric	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	197.22	205.24	221.33	246.03	278.81
Net income per share	5.1	5.48	6	3.29	6.49
Operating cash flow per share	9.88	12.12	13.85	12.33	10.45
Free cash flow per share	7.99	10.26	11.94	10.25	8.09
Cash per share	6.19	8.29	11.82	12.09	8.98
Book value per share	49.09	53.01	56.92	54.47	59.5
Tangible book value per share	-37.43	-31.32	-24.84	-23.73	-11.39
Share holders equity per share	49.09	53.01	56.92	54.47	59.5
Interest debt per share	55.58	52.03	44.76	41.77	50.32
Market cap	96.94B	88.23B	136.33B	121.96B	101.22B
Enterprise value	180.26B	165.41B	199.86B	179.61B	172.32B
P/E ratio	14.62	12.29	17.24	28.29	12.13
Price to sales ratio	0.38	0.33	0.47	0.38	0.28
POCF ratio	7.54	5.56	7.46	7.54	7.54
PFCF ratio	9.33	6.57	8.66	9.07	9.74
P/B Ratio	1.52	1.27	1.82	1.71	1.32
PTB ratio	1.52	1.27	1.82	1.71	1.32
EV to sales	0.7	0.62	0.68	0.56	0.48
Enterprise value over EBITDA	10.58	9.01	10.28	8.62	8.64
EV to operating cash flow	14.03	10.43	10.94	11.1	12.83
EV to free cash flow	17.35	12.32	12.69	13.35	16.58
Earnings yield	0.07	0.08	0.06	0.04	0.08
Free cash flow yield	0.11	0.15	0.12	0.11	0.1
Debt to equity	1.09	0.94	0.75	0.73	0.81
Debt to assets	0.31	0.27	0.24	0.22	0.24
Net debt to EBITDA	4.89	4.2	3.27	2.77	3.56
Current ratio	0.94	0.91	0.88	0.95	0.86
Interest coverage	4.21	4.85	6.05	7.31	5.9
Income quality	1.94	2.21	2.31	3.75	1.61
Dividend Yield	0.03	0.03	0.02	0.02	0.03
Payout ratio	0.39	0.37	0.33	0.67	0.38
Sales general and administrative to revenue	0.13	0.13	0.12	0.12	0
Research and developement to revenue	0	0	0	0	0
Intangibles to total assets	0.5	0.46	0.45	0.44	0.35
Capex to operating cash flow	-0.19	-0.15	-0.14	-0.17	-0.23
Capex to revenue	-0.01	-0.01	-0.01	-0.01	-0.01
Capex to depreciation	-0.57	-0.55	-0.56	-0.65	-0.69
Stock based compensation to revenue	0	0	0	0	-0.03
Graham number	75.02	80.88	87.64	63.46	93.24
ROIC	0.06	0.07	0.07	0.09	0.07
Return on tangible assets	0.06	0.06	0.06	0.03	0.05
Graham Net	-98.84	-101.13	-92.74	-90.31	-104.37
Working capital	-3B	-5.65B	-7.8B	-3.79B	-11.33B
Tangible asset value	-48.7B	-40.99B	-32.77B	-31.14B	-14.64B
Net current asset value	-109.82B	-112.42B	-105.11B	-98.73B	-113.24B
Invested capital	1.09	0.94	0.75	0.73	0.81
Average receivables	17.84B	20.68B	23.09B	25.85B	31.25B
Average payables	19.95B	32.92B	36.78B	41.54B	47.11B
Average inventory	16.98B	18.01B	18.13B	18.43B	18.56B
Days sales outstanding	27.91	29.54	30.55	30.84	35.89
Days payables outstanding	53.51	57.94	58.81	60.48	59.95
Days of inventory on hand	30.26	30.73	27	26	21.69
Receivables turnover	13.08	12.36	11.95	11.83	10.17
Payables turnover	6.82	6.3	6.21	6.03	6.09
Inventory turnover	12.06	11.88	13.52	14.04	16.83
ROE	0.1	0.1	0.11	0.06	0.11
Capex per share	-1.89	-1.86	-1.91	-2.08	-2.36

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q4

Metric	2022-12-31	2023-03-31	2023-06-30	2023-09-30	2023-12-31
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	64.03	66.55	69.38	69.86	72.95
Net income per share	1.76	1.66	1.48	1.76	1.59
Operating cash flow per share	-1.49	5.8	4.6	2.11	-2.05
Free cash flow per share	-2.02	5.03	4.14	1.69	-2.75
Cash per share	12.11	13.89	13.23	12.65	8.96
Book value per share	54.21	55.64	56.68	57.76	59.36
Tangible book value per share	-24.11	-30.28	-37.71	-36.03	-11.36
Share holders equity per share	54.21	55.64	56.68	57.76	59.36
Interest debt per share	40.51	47.15	51.63	49.99	48.69
Market cap	121.78B	95.55B	89.18B	90.01B	101.46B
Enterprise value	179.42B	157.3B	157.42B	156.97B	172.55B
P/E ratio	13.23	11.18	11.73	9.95	12.4
Price to sales ratio	1.45	1.12	1	1	1.08
POCF ratio	-62.39	12.85	15.1	33.14	-38.49
PFCF ratio	-46.13	14.8	16.77	41.46	-28.6
P/B Ratio	1.71	1.34	1.23	1.21	1.33
PTB ratio	1.71	1.34	1.23	1.21	1.33
EV to sales	2.14	1.84	1.77	1.75	1.84
Enterprise value over EBITDA	37.26	31.82	30.93	31	35.56
EV to operating cash flow	-91.92	21.15	26.65	57.79	-65.46
EV to free cash flow	-67.96	24.37	29.61	72.3	-48.65
Earnings yield	0.02	0.02	0.02	0.03	0.02
Free cash flow yield	-0.02	0.07	0.06	0.02	-0.03
Debt to equity	0.74	0.84	0.9	0.86	0.81
Debt to assets	0.22	0.25	0.26	0.25	0.24
Net debt to EBITDA	11.97	12.49	13.41	13.22	14.65
Current ratio	0.94	0.92	0.86	0.86	0.86
Interest coverage	6.88	6.73	5.62	5.72	5.44
Income quality	-0.85	3.48	3.11	1.2	-1.29
Dividend Yield	0.01	0.01	0.01	0.01	0.01
Payout ratio	0.31	0.36	0.42	0.34	0.38
Sales general and administrative to revenue	0.11	0	0	0	0
Research and developement to revenue	0	0	0	0	0
Intangibles to total assets	0.44	0.46	0.49	0.48	0.35
Capex to operating cash flow	0.35	-0.13	-0.1	-0.2	0.35
Capex to revenue	-0.01	-0.01	-0.01	-0.01	-0.01
Capex to depreciation	-0.66	-0.98	-0.54	-0.48	-0.8
Stock based compensation to revenue	0	0	0	0	-0.08
Graham number	46.3	45.65	43.47	47.78	46.06
ROIC	0.02	0.02	0.02	0.02	0.02
Return on tangible assets	0.02	0.02	0.01	0.02	0.01
Graham Net	-90.9	-93.17	-100.77	-98.55	-104.13
Working capital	-4.05B	-6.35B	-11.45B	-11.41B	-11.33B
Tangible asset value	-31.59B	-38.85B	-48.38B	-46.38B	-14.64B
Net current asset value	-99.27B	-99.04B	-109.31B	-106.65B	-113.24B
Invested capital	0.74	0.84	0.9	0.86	0.81
Average receivables	26.92B	27.8B	28.94B	31.24B	34.08B
Average payables	44.05B	44.07B	44.63B	47.35B	49.37B
Average inventory	18.57B	18.68B	17.78B	17.62B	17.99B
Days sales outstanding	29.27	29.86	29.87	32.96	33.74
Days payables outstanding	57.4	54.41	54.71	57.79	56.09
Days of inventory on hand	24.53	22.86	20.66	21.21	20.29
Receivables turnover	3.08	3.01	3.01	2.73	2.67
Payables turnover	1.57	1.65	1.65	1.56	1.6
Inventory turnover	3.67	3.94	4.36	4.24	4.43
ROE	0.03	0.03	0.03	0.03	0.03
Capex per share	-0.53	-0.77	-0.46	-0.42	-0.71

0HRS.L Dividend History

0HRS.L Frequently Asked Questions

What is CVS Health Corporation stock symbol ?

CVS Health Corporation is a US stock , located in Woonsocket of Ri and trading under the symbol 0HRS.L

What is CVS Health Corporation stock quote today ?

CVS Health Corporation stock price is $68.96 today.

Is CVS Health Corporation stock public?

Yes, CVS Health Corporation is a publicly traded company.

Something similar

Top by Market Cap

Top Correlated ETFs

Top Correlated Stocks

Similar Market Cap

Company Profile

Volume Average 34.8K
Market Capitalization 86.55B
Employee 219K
CEO Ms. Karen Sue Lynch
Headquarters Woonsocket,RI,US
IPO Date 2018-01-29
Website https://www.cvshealth.com

CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. Its Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, plans offered on public health insurance and private health insurance exchanges, other sponsors of health benefit plans, and individuals. This segment operates retail specialty pharmacy stores; and specialty mail-order, mail-order dispensing, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The company's Retail/LTC segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products; and provides health care services through its MinuteClinic walk-in medical clinics. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. As of December 31, 2021, it operated approximately 9,900 retail locations and 1,200 MinuteClinic locations, as well as online retail pharmacy websites, LTC pharmacies, and onsite pharmacies. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.